Infection Risks And Government Laws will restrict Injectable Drug Delivery Market through 2016-2021

The Global Injectable Drug Delivery Devices Market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and self-injection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report.

Browse Injectable Drug Delivery Market Research @–formulations-selfinjection-devices-pen-needle-free–auto-injectors-autoimmune-diseases-diabetes-oncology-hormonal-disorders-liposomes-microspheres-othersforecast20152020

While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6%during 2013 – 2018. Conventional injection devices hold around 87% market share currently but this is expected todecrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years.

The global injectable drug delivery devices market is expected to increase from around $ 11.6 bn in 2013 to around $ 17.5 bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 – 2018.

Injectable Drug Delivery Market – By Type

  • Pharmaceutical Drug Formulations
  • By Device
  • Conventional Devices
  • Auto Injector Devices
  • Self Injector Devices
  • Pen Injectors
  • Needle Free Injector Devices
  • Others

Injectable Drug Delivery Market – By Type of Diseases

  • Anemia
  • Diabetes
  • Multiple sclerosis
  • Rheumatoid
  • Crohn’s
  • Others

Injectable Drug Delivery Market -Geographic Analysis

  • Introduction
  • North America
  • South & Central America
  • Europe
  • APAC
  • ROW

Injectable Drug Delivery Market Entropy

  • New Product Launches
  • M&As, Collaborations, JVs and Partnerships

Injectable Drug Delivery Market Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)

  • Becton Dickinson and Company (BD)
  • Baxter International Inc.
  • Consort Medical PLC
  • Crossject SA
  • Eli Lilly and Company
  • Elcam Medical
  • Novo Nordisk
  • Owen Mumford Ltd
  • Sanofi
  • Schott AG
  • Terumo Corporation
  • Ypsomed Holding AG
  • Others

Get Sample Brochure of Report @

Analyzing the competitive landscape of the global conventional injectable devices market for 2012 IndustryARC is of the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%.


Order Injectable Drug Delivery Market Research Report @

About us:

MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.

Contact us:
Sales Manager
Mayur S

2711 Centerville Road, Suite 400,
United States
Telephone: 1-302-261-5343

Designed by
Powered by